Microbot Medical Inc. MBOT
Set alert
At close
Pre-market · Nov 2, 8:47 AM ET
- YTD
- -45.50%
- 1 year
- -51.12%
- Open
- 1.11
- Prev close
- 1.12
- Mkt cap
- 73.21M
- Vol
- 1.33M
- Avg vol
- 716.74K
- EPS
- -0.25
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.04
- High
- 1.11
- Forward P/E
- -1.87
- Beta
- 1.63
- Short ratio
- 2.65
- Inst. own
- 7.46%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.9736
- 200-d avg
- 1.00
- 1y target
- 0.00
5D chart
Signals (61)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:00 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:20 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:45 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:25 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 11:45 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 10:30 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 3 days ago |
| RSI: Overbought | Oct 29, 3:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 2:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:40 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 2:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:00 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 11:00 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 10:10 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:05 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 9:35 AM | 4 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:30 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:20 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:05 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:00 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:15 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:15 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 11:20 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 11:00 AM | 4 days ago |
| RSI: Overbought | Oct 28, 10:25 AM | 4 days ago |
| RSI: Overbought | Oct 28, 10:00 AM | 4 days ago |
| RSI: Overbought | Oct 28, 9:50 AM | 4 days ago |
| RSI: Overbought | Oct 28, 9:35 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:30 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 3:20 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 2:50 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:10 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:40 AM | 5 days ago |
| RSI: Overbought | Oct 27, 11:35 AM | 5 days ago |
| RSI: Overbought | Oct 27, 10:50 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:35 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:10 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:30 AM | 6 days ago |
| RSI: Overbought | Oct 27, 9:30 AM | 6 days ago |
| SMA: Bullish | Oct 26, 3:50 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 3:30 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:25 PM | 6 days ago |
| RSI: Oversold | Oct 26, 2:25 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:15 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:30 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 1:30 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:25 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:20 PM | 6 days ago |
| SMA: Bearish | Oct 26, 11:55 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:30 AM | 6 days ago |
| SMA: Bullish | Oct 26, 10:20 AM | 6 days ago |
News
-
6 days ago benzinga.com
Microbot Medical Receives Order From ELMNT IR For 12-Month Supply Of Liberty Devices
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY Endovascular Robotic System, today announced that ELMNT IR, a multisite outpatient interventional radiology…
6 days ago globenewswire.com
Microbot Medical® Secures its First Office-Based Lab (OBL) Customer for the LIBERTY® Endovascular Robotic System
ELMNT IR also became the first account on the West Coast, marking a geographic expansion which aligns with the Company's Full Market Release strategy. The Company believes the OBLs represent a…
-
1 week ago benzinga.com
Citizens Initiates Coverage On Microbot Medical with Market Outperform Rating, Announces Price Target of $2.5
Citizens analyst Daniel Stauder initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Market Outperform rating and announces Price Target of $2.5.
-
1 week ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 price target.
-
1 week ago benzinga.com
Microbot Medical Receives Several New Patent Approvals Across US, Japan, China And Canada, Further Strengthening Its Global IP Portfolio
The Company now holds 44 issued patents and 49 pending patents globally. Commercialization continues to advance across both U.S. and international markets.HINGHAM, Mass., Oct. 20, 2026 (GLOBE…
-
3 weeks ago benzinga.com
Microbot Medical Inks Three-Year Distribution Deal With Medtechnica To Advertise, Sell LIBERTY System In Israel
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it has signed a three-year exclusive commercial distribution…
-
2 months ago benzinga.com
B. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4
B. Riley Securities analyst Anderson Schock reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and lowers the price target from $5 to $4.
-
2 months ago benzinga.com
Microbot Medical Q2 EPS $(0.08), Inline, Sales $241.000K Miss $340.000K Estimate
Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.10) per share from the same…
-
3 months ago benzinga.com
Microbot Medical Reports 100% Growth In Revenue, New Clients In Q2
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, is reporting greater than 100% growth in revenue and new customers for the…
-
4 months ago benzinga.com
Microbot Medical Signs Letter With Manufacturer Sanmina To Produce Its LIBERTY Single-Use, Remotely Operated Endovascular Robotic System
As momentum continues to rise in the U.S., reflected in increased accounts and usage across several states, and with the momentum building in the international markets as seen with the recent…
-
4 months ago benzinga.com
Microbot Medical Inks Agreement With Lovell Government Services To Serve Federal Healthcare Systems
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into an agreement with Lovell® Government Services to serve federal…
-
5 months ago benzinga.com
LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $4.
-
5 months ago benzinga.com
Microbot Medical Receives Israel's Marketing Clearance For Its LIBERTY System
Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it has achieved a significant regulatory milestone as Israel…
-
5 months ago benzinga.com
Watching Microbot Medical; Shares See Volume To The Downside; White Diamond Research Issues Report On Co
https://whitediamondresearch.com/research/we-interviewed-some-of-the-first-surgeons-to-use-microbot-medicals-liberty-endovascular-robotic-system-and-its-clear-that-it-will-be-a-commercial-failure-1-pr…
-
6 months ago benzinga.com
Microbot Medical Announces LIBERTY System Gains Clinical Validation And Early Commercial Adoption As Global Expansion Accelerates
Commercial adoption of the LIBERTY System by sites that participated in the clinical trial serves as a strong validation of the value it brings to everyday practiceThe Company will attend the Annual…
-
6 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 price target.
-
6 months ago benzinga.com
Microbot Medical Completes Limited Market Release Of Its LIBERTY Endovascular Robotic System, With Commencement Of Full Market Release In The U.S. Proceeding As Planned
To date, LIBERTY has been adopted by multiple healthcare systems with dozens of hospitals in their networks, including globally recognized hospitals such as Emory Healthcare and Tampa General…
-
7 months ago benzinga.com
Microbot Medical Q4 EPS $(0.04) Beats $(0.06) Estimate
Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 78.95 percent increase over losses of…
-
7 months ago benzinga.com
Emory Healthcare Announces Successful Use Of Microbot Medical's Liberty System In Robotic Peripheral Endovascular Procedures
Emory interventional radiologists have now demonstrated successful use of the LIBERTY System on benign prostatic hyperplasia (BPH, commonly known as enlarged prostate), as well as liver cancer.
-
8 months ago benzinga.com
Microbot Medical Commends American Medical Association's Expanding Efforts To Protect Health Care Professionals From Ionizing Radiation
Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, commends the American Medical Association's (AMA) expanding efforts to protect…
8 months ago benzinga.com
Tampa General Hospital Adopts Small-Cap Microbot Medical's Robotic System
Microbot Medical stock jumps after Tampa General adopts its FDA-cleared LIBERTY robotic system ahead of April 2026 launch.
-
8 months ago benzinga.com
Microbot Medical Highlights LIBERTY Endovascular Robotic System At ISET Conference
International Symposium on Endovascular Therapy (ISET) Convened Key Opinion Leaders to Discuss Advancements and Future Role of Endovascular RoboticsLIBERTY® Continues to Gain Commercial Traction and…
8 months ago benzinga.com
Looking Into Microbot Medical Inc's Recent Short Interest
Looking Into Microbot Medical Inc's Recent Short Interest
8 months ago benzinga.com
This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tuesday
This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tuesday
-
8 months ago benzinga.com
B. Riley Securities Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5
B. Riley Securities analyst Anderson Schock initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $5.
8 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
8 months ago benzinga.com
Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
-
9 months ago benzinga.com
Microbot Medical Says It Enters 2026 With Market Momentum Following FDA 510(k) Clearance Of LIBERTY, Single‑Use Endovascular Robotic System
Limited Market Release (LMR) of the LIBERTY® System is on ScheduleBuilding on Positive Customer Feedback and Growing Market Enthusiasm, the Company Prepares for Full Market Release (FMR) in…
-
11 months ago benzinga.com
Roth Capital Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5.5
Roth Capital analyst Kyle Bauser initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $5.5.
-
11 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 price target.
-
11 months ago benzinga.com
Microbot Medical Says Emory University Hospital Adopts LIBERTY For Patient Care; Microbot Collaborates With Emory To Establish Endovascular Robotics Program In Interventional Radiology
Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY Endovascular Robotic System, announced that Emory University Hospital, a nationally recognized academic…
-
12 months ago benzinga.com
Microbot Medical Announces Commercial Availability Of LIBERTY Robotic System In U.S.
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that its LIBERTY® System, the first FDA cleared single-use, remotely…
-
1 year ago benzinga.com
Microbot Medical Announces It Will Exhibit Its Liberty Endovascular Robotic System At Symposium On Clinical Interventional Oncology In Miami, Fl, October 17-19, 2025, Marking First Commercial Exhibition Of The System Following Its FDA 510(K) Clearance In September 2025
Microbot Medical Inc. (NASDAQ:MBOT), developer and distributer of the innovative LIBERTY® Endovascular Robotic System, today announced that it will be exhibiting the LIBERTY® System at the upcoming…
-
1 year ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 price target.
-
1 year ago benzinga.com
Microbot Medical Partners With U.S. Based 3PL Company To Support Commercialization Of FDA-Cleared LIBERTY System
The Experienced MedTech Logistics Provider Will Help Ensure Effective and Efficient Inventory Management and Customer Support The Company is on Track to Commence the Launch of LIBERTY® during Q4 This
-
1 year ago benzinga.com
Microbot Medical Announces That The Japanese Patent Office Has Granted The Company Its First Patent In Japan, Covering The Core LIBERTY System Technology
Commercial Focus Remains on U.S. Market as it Continues to Explore Certain Global Markets that Accept FDA Cleared Devices Protecting its Innovative Technology Remains a Priority and Momentum…
1 year ago benzinga.com
Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
1 year ago benzinga.com
Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
1 year ago benzinga.com
Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
1 year ago benzinga.com
Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket
Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket
-
2 years ago benzinga.com
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
-
2 years ago benzinga.com
Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
-
2 years ago benzinga.com
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
-
2 years ago benzinga.com
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update.
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
2 years ago benzinga.com
Gold Moves Lower; US Crude Stocks Decline Last Week
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.27% to 37,758.26 while the NASDAQ rose 0.17% to 15,124.90.…